Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Johnson & Johnson says it can provide 20M vaccine doses by late March
Source: Politico
Johnson & Johnson can deliver 20 million doses of its single-shot coronavirus vaccine to the U.S. government by the end of March, an executive will testify tomorrow.
Assuming necessary regulatory approvals relating to our manufacturing processes, our plan is to begin shipping immediately upon emergency use authorization, and deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans, Johnson & Johnsons Richard Nettles, vice president of medical affairs for the company's pharmaceutical unit Janssen, will tell a House Energy & Commerce subcommittee Tuesday.
The company has applied to the Food and Drug Administration for emergency authorization. FDA is expected to grant that as early as this weekend, after an expert FDA panel convenes Friday to discuss the effectiveness and safety of J&Js vaccine.
Why it matters: White House officials had cautioned that initial supply of the Johnson & Johnson vaccine would be limited because of production problems, although the company has said it will meet its agreement to supply the U.S. with 100 million doses by the end of June.
Assuming necessary regulatory approvals relating to our manufacturing processes, our plan is to begin shipping immediately upon emergency use authorization, and deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans, Johnson & Johnsons Richard Nettles, vice president of medical affairs for the company's pharmaceutical unit Janssen, will tell a House Energy & Commerce subcommittee Tuesday.
The company has applied to the Food and Drug Administration for emergency authorization. FDA is expected to grant that as early as this weekend, after an expert FDA panel convenes Friday to discuss the effectiveness and safety of J&Js vaccine.
Why it matters: White House officials had cautioned that initial supply of the Johnson & Johnson vaccine would be limited because of production problems, although the company has said it will meet its agreement to supply the U.S. with 100 million doses by the end of June.
Read more: https://www.politico.com/news/2021/02/22/johnson-johnson-vaccine-march-470994
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
3 replies, 1517 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (7)
ReplyReply to this post
3 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Johnson & Johnson says it can provide 20M vaccine doses by late March (Original Post)
brooklynite
Feb 2021
OP
speak easy
(9,234 posts)1. J&J's single shot does slightly better than a single shot of Pfizer.
but presumably lasts longer.
They would be better waiting for the results of a two shot regime currently in Phase 3.
thesquanderer
(11,986 posts)2. Except that waiting ultimately costs lives.
The more people we can vaccinate sooner rather than later, the more lives we save. Another example of not wanting to let the perfect be the enemy of the good. Get this one out to people now. You can always transition to 2-shot later if that turns out to be better. Also, probably everyone's going to need to do it again next year regardless. So whatever best gets us through the NOW is what we need.
IronLionZion
(45,426 posts)3. Or give the single shot now
and then if the research shows value to having a second shot, they can give a booster later. We need as many people as possible to get at least the first shot.